Nothing Special   »   [go: up one dir, main page]

WO2002077604A3 - Cellules marquees servant de temoin fonctionnel interne dans des essais de detection de cellules rares - Google Patents

Cellules marquees servant de temoin fonctionnel interne dans des essais de detection de cellules rares Download PDF

Info

Publication number
WO2002077604A3
WO2002077604A3 PCT/US2002/006967 US0206967W WO02077604A3 WO 2002077604 A3 WO2002077604 A3 WO 2002077604A3 US 0206967 W US0206967 W US 0206967W WO 02077604 A3 WO02077604 A3 WO 02077604A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell detection
labeled cells
detection assays
functional control
rare cell
Prior art date
Application number
PCT/US2002/006967
Other languages
English (en)
Other versions
WO2002077604A2 (fr
Inventor
Leon W M M Terstappen
Galla Chandra Rao
Herman Rutner
Paul A Liberti
Original Assignee
Immunivest Corp
Leon W M M Terstappen
Galla Chandra Rao
Herman Rutner
Paul A Liberti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunivest Corp, Leon W M M Terstappen, Galla Chandra Rao, Herman Rutner, Paul A Liberti filed Critical Immunivest Corp
Priority to DE60238493T priority Critical patent/DE60238493D1/de
Priority to AU2002311773A priority patent/AU2002311773A1/en
Priority to AT02739098T priority patent/ATE490466T1/de
Priority to EP02739098A priority patent/EP1429603B1/fr
Priority to JP2002575608A priority patent/JP2004534210A/ja
Publication of WO2002077604A2 publication Critical patent/WO2002077604A2/fr
Publication of WO2002077604A3 publication Critical patent/WO2002077604A3/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00—Magnetic separation
    • B03C1/005—Pretreatment specially adapted for magnetic separation
    • B03C1/01—Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y25/00—Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
    • H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
    • H01F1/0054—Coated nanoparticles, e.g. nanoparticles coated with organic surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

L'invention concerne des cellules témoins stabilisées, des procédés servant à les préparer et des trousses contenant ces cellules stabilisées. Elle concerne également des procédés améliorés servant à détecter des cellules rares dans des spécimens biologiques.
PCT/US2002/006967 2001-03-07 2002-03-07 Cellules marquees servant de temoin fonctionnel interne dans des essais de detection de cellules rares WO2002077604A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE60238493T DE60238493D1 (de) 2001-03-07 2002-03-07 Is von seltenen zellen verwendete markierte zellen
AU2002311773A AU2002311773A1 (en) 2001-03-07 2002-03-07 Labeled cells for use as an internal functional control in rare cell detection assays
AT02739098T ATE490466T1 (de) 2001-03-07 2002-03-07 Als interne funktionskontrolle in tests zum nachweis von seltenen zellen verwendete markierte zellen
EP02739098A EP1429603B1 (fr) 2001-03-07 2002-03-07 Cellules marquees servant de temoin fonctionnel interne dans des essais de detection de cellules rares
JP2002575608A JP2004534210A (ja) 2001-03-07 2002-03-07 希少細胞検出アッセイにおける内部機能対照として用いる標識細胞

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/801,471 US20010018192A1 (en) 1998-02-12 2001-03-07 Labeled cells for use as an internal functional control in rare cell detection assays
US09/801,471 2001-03-08

Publications (2)

Publication Number Publication Date
WO2002077604A2 WO2002077604A2 (fr) 2002-10-03
WO2002077604A3 true WO2002077604A3 (fr) 2004-04-01

Family

ID=25181182

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/006967 WO2002077604A2 (fr) 2001-03-07 2002-03-07 Cellules marquees servant de temoin fonctionnel interne dans des essais de detection de cellules rares

Country Status (11)

Country Link
US (1) US20010018192A1 (fr)
EP (2) EP2280283B1 (fr)
JP (1) JP2004534210A (fr)
AT (1) ATE490466T1 (fr)
AU (1) AU2002311773A1 (fr)
DE (1) DE60238493D1 (fr)
DK (1) DK2280283T3 (fr)
ES (2) ES2527210T3 (fr)
HK (1) HK1152378A1 (fr)
PT (1) PT2280283E (fr)
WO (1) WO2002077604A2 (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282350B2 (en) 1998-02-12 2007-10-16 Immunivest Corporation Labeled cell sets for use as functional controls in rare cell detection assays
AU772603B2 (en) * 1998-10-29 2004-05-06 Cell Works Diagnostics, Inc. Multiple marker characterization of single cells
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
EP1481248A2 (fr) * 2002-03-01 2004-12-01 Cardiff & Vale National Health service Trust Universitiy Hospital of Wales Procedes de numeration absolue de cellules
EP2359689B1 (fr) 2002-09-27 2015-08-26 The General Hospital Corporation Dispositif microfluidique pour la séparation de cellules et usage du dispositif
CA2445204C (fr) 2002-10-16 2014-08-12 Streck Laboratories, Inc. Methode et dispositif de prelevement et de conservation de cellules aux fins d'analyse
ATE489452T1 (de) 2003-02-27 2010-12-15 Veridex Llc Zirkulierende tumorzellen (ctc's): frühe beurteilung von time-to-progression, überleben und ansprechen auf therapie bei patienten mit metastasiertem krebs
JP4629675B2 (ja) * 2003-09-18 2011-02-09 ベリデックス・リミテッド・ライアビリティ・カンパニー オペレーター不要のプログラム可能な試料調製および分析システム
CA2535922A1 (fr) * 2003-09-23 2005-04-07 University Of Missouri Procede de synthese de polynucleotides a l'aide d'enzymes thermostable
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070128668A1 (en) * 2005-12-01 2007-06-07 Larry Burg Quantitative use of tracer cells
US8337755B2 (en) 2006-03-13 2012-12-25 Veridex, Llc Operator independent programmable sample preparation and analysis system
DK2027470T3 (da) 2006-06-02 2013-02-04 Pfizer Prod Inc Analyse for cirkulerende tumorceller
WO2008008515A2 (fr) 2006-07-14 2008-01-17 Aviva Biosciences Corporation Procédés et compositions servant à détecter des cellules rares dans un échantillon biologique
US8110101B2 (en) 2007-08-30 2012-02-07 Veridex, Llc Method and apparatus for imaging target components in a biological sample using permanent magnets
US7828968B2 (en) 2007-08-30 2010-11-09 Veridex, Llc Method and apparatus for imaging target components in a biological sample using permanent magnets
KR101604649B1 (ko) * 2007-11-27 2016-03-18 베리덱스, 엘엘씨 혈액 내 순환 흑색종 세포의 자동화된 계산 및 특징화
US8710836B2 (en) 2008-12-10 2014-04-29 Nanomr, Inc. NMR, instrumentation, and flow meter/controller continuously detecting MR signals, from continuously flowing sample material
US11634747B2 (en) * 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
EP3778919A1 (fr) 2009-02-18 2021-02-17 Streck Inc. Préservation d'acides nucléiques acellulaires
EP3103883A1 (fr) * 2009-11-09 2016-12-14 Streck, Inc. Stabilisation de l'arn et extraction de l'arn dans des cellules intactes dans un échantillon de sang
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9645154B2 (en) 2010-12-24 2017-05-09 Arkray, Inc. Method for detecting cancer cell
US9956281B2 (en) 2011-05-04 2018-05-01 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
US9535065B2 (en) * 2011-09-06 2017-01-03 Becton, Dickinson And Company Methods and compositions for cytometric detection of rare target cells in a sample
US20150056649A1 (en) 2012-01-13 2015-02-26 Konica Minolta, Inc. Method for quantifying cell of interest in blood, and method for evaluating system for quantifying said cell
EP2903603A4 (fr) * 2012-09-27 2016-08-10 Cynvenio Biosystems Inc Microparticules sensibles à un stimulus et procédés d'utilisation
EP2917362A4 (fr) * 2012-11-07 2016-07-13 Sandstone Diagnostics Inc Procédés et dispositifs de traitement d'échantillons et de numération de cellules
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US10376877B2 (en) 2013-02-07 2019-08-13 Sandstone Diagnostics, Inc. Automated sample processing, fluid distribution, and sedimentation assay
US20150233932A1 (en) * 2013-02-19 2015-08-20 Ching-Ping Tseng Methods, Systems, and Compositions for Enrichment of Rare Cells
WO2015013244A1 (fr) 2013-07-24 2015-01-29 Streck, Inc. Compositions et méthodes de stabilisation de cellules tumorales circulantes
WO2015017535A2 (fr) * 2013-08-02 2015-02-05 Siemens Healthcare Diagnostics Inc. Cellules témoins et procédé associé
JP6331524B2 (ja) * 2014-03-14 2018-05-30 日立化成株式会社 標準細胞液
CN104568923A (zh) * 2014-12-01 2015-04-29 浙江省肿瘤医院 电化学发光检测外周血循环肿瘤细胞抗原的方法及试剂盒
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
JP6582486B2 (ja) * 2015-03-27 2019-10-02 コニカミノルタ株式会社 血液中の稀少細胞検出方法
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
WO2018022991A1 (fr) 2016-07-29 2018-02-01 Streck, Inc. Composition de suspension pour contrôle d'analyse hématologique
JP6485576B2 (ja) * 2018-04-19 2019-03-20 日立化成株式会社 標準細胞液

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432089A (en) * 1992-03-02 1995-07-11 Streck Laboratories, Inc. Reference control for use with manual and flow cytometric reticulocyte counting devices
US5763204A (en) * 1992-09-14 1998-06-09 Coulter Corporation Preparation of preserved, non-infectious control cell for use in the identification of a disease through blood testing
US5776754A (en) * 1991-02-17 1998-07-07 The Curators Of The University Of Missouri Preserved cell preparations for flow cytometry and immunology

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188935A (en) * 1984-05-31 1993-02-23 Coulter Electronics, Inc. Reagent system and method for identification, enumeration and examination of classes and subclasses of blood leukocytes
US5597531A (en) * 1985-10-04 1997-01-28 Immunivest Corporation Resuspendable coated magnetic particles and stable magnetic particle suspensions
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US5187099A (en) * 1986-10-29 1993-02-16 Coulter Corporation Control slide for immunoassay kit using a low-temperature melting paraffin
JP2619911B2 (ja) 1988-04-08 1997-06-11 東亜医用電子株式会社 網状赤血球測定装置用標準血液
US5059518A (en) * 1988-10-20 1991-10-22 Coulter Corporation Stabilized lyophilized mammalian cells and method of making same
US5698271A (en) * 1989-08-22 1997-12-16 Immunivest Corporation Methods for the manufacture of magnetically responsive particles
US5610022A (en) * 1989-09-26 1997-03-11 City Of Hope Internal control for immunocytochemistry assay
IE76319B1 (en) 1990-07-23 1997-10-22 Becton Dickinson Co Preservation of cells as controls or standards in cellular analysis
US5270208A (en) * 1991-05-09 1993-12-14 Streck Laboratories, Inc. White blood cell hematology control
AU669692B2 (en) * 1992-02-24 1996-06-20 Coulter International Corporation Suspension media for hematological composition and method for its use
US5342754A (en) * 1992-09-14 1994-08-30 Coulter Corporation Preserved, non-infectious control cell for use in the identification of a disease through blood testing
AU6024294A (en) * 1993-01-08 1994-08-15 Coulter Corporation Method of using preserved control cells in the calibration of fluorescent and light scatter measurements
DE69428552T2 (de) * 1993-01-26 2002-04-11 Becton Dickinson And Co., Franklin Lakes Verfahren zum Nachweis von seltenen Ereignissen
US5629933A (en) * 1995-06-07 1997-05-13 International Business Machines Corporation Method and system for enhanced communication in a multisession packet based communication system
JP3875754B2 (ja) * 1995-11-17 2007-01-31 シスメックス株式会社 フローサイトメータ用標準液
US5985153A (en) * 1996-06-07 1999-11-16 Immunivest Corporation Magnetic separation apparatus and methods employing an internal magnetic capture gradient and an external transport force
US5968831A (en) * 1996-10-29 1999-10-19 Coulter International Corp. Cell control used to confirm enzymatic activity
WO2000002049A1 (fr) * 1998-07-01 2000-01-13 Nitto Denko Corporation Test immunologique et kit de test immunologique
ES2274781T3 (es) * 1999-04-13 2007-06-01 Wilex Ag Empleo diagnostico y terapeutico de anticuerpos contra el receptor de la urocinasa.
GB0022017D0 (en) * 2000-09-08 2000-10-25 Univ Dundee Cell assays

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776754A (en) * 1991-02-17 1998-07-07 The Curators Of The University Of Missouri Preserved cell preparations for flow cytometry and immunology
US5432089A (en) * 1992-03-02 1995-07-11 Streck Laboratories, Inc. Reference control for use with manual and flow cytometric reticulocyte counting devices
US5763204A (en) * 1992-09-14 1998-06-09 Coulter Corporation Preparation of preserved, non-infectious control cell for use in the identification of a disease through blood testing

Also Published As

Publication number Publication date
PT2280283E (pt) 2015-02-03
EP1429603A2 (fr) 2004-06-23
DK2280283T3 (en) 2014-11-17
EP1429603B1 (fr) 2010-12-01
ES2527210T3 (es) 2015-01-21
EP2280283B1 (fr) 2014-10-15
JP2004534210A (ja) 2004-11-11
ES2357101T3 (es) 2011-04-18
WO2002077604A2 (fr) 2002-10-03
ATE490466T1 (de) 2010-12-15
EP2280283A1 (fr) 2011-02-02
HK1152378A1 (en) 2012-02-24
EP1429603A4 (fr) 2004-08-18
AU2002311773A1 (en) 2002-10-08
DE60238493D1 (de) 2011-01-13
US20010018192A1 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
WO2002077604A3 (fr) Cellules marquees servant de temoin fonctionnel interne dans des essais de detection de cellules rares
WO2003048300A3 (fr) Procedes d'identification de molecules cibles cellulaires
AU3227400A (en) Flow cell, analyte measurement apparatus and methods related thereto
AU2003293015A1 (en) Microporous materials, methods, and articles for localizing and quantifying analytes
AU2002300939A1 (en) Reagents and Methods for Detecting Analytes, and Devices Comprising Reagents for Detecting Analytes
WO2002029600A3 (fr) Procede et dispositif
AU2002230650A1 (en) Method for diagnosing pathology in biological samples
AU1461702A (en) Microvolume immunoabsorbant assays with amplified electrochemical detection
WO2005106036A3 (fr) Methodes et compositions pour analyser des analytes
WO2007086900A3 (fr) Analyses de recherche de stilbazium
AU2002303343A1 (en) Methods and reagents for cell transplantation
WO2002008461A3 (fr) Methodes d'analyse et d'identification de genes transcrits et empreinte genetique
WO2006036735A3 (fr) Procede de detection et de quantification de multiples composants subcellulaires
AU2003229455A1 (en) Rapid vaccinia antibody detection device, method and test kit
AU2002353443A1 (en) Kits and methods for preparing cell samples optimized for dual staining
WO2006099537A3 (fr) Utilisation de systemes d'antigenes a substituts d'anticorps a des fins de detection d'analytes
AU2002332088A1 (en) Methods and reagents for improved cell-based assays
CA2407760A1 (fr) Methodes pour le diagnostic de l'astrocytome de bas grade
WO2005028621A3 (fr) Essais biologiques sur des cellules primaires
WO2004010143A3 (fr) Dispositifs electrochimiques a ecoulement lateral et a ecoulement continu
AU2002244757A1 (en) Method for specifically detecting, isolating and characterizing cells from body samples by transfecting nucleic acid constructs
WO2002090989A3 (fr) Procede permettant de detecter des antigenes de globules sanguins et des anticorps diriges contre ces antigenes
WO2005014847A3 (fr) Reactifs, methodes et necessaires de detection d'enzymes pour l'alimentation des animaux
WO2002044733A3 (fr) Procedes et compositions de tri et/ou de determination d'organismes
EP2407787A3 (fr) Procédé de détection de l'expression L523S dans des échantillons biologiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002739098

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002575608

Country of ref document: JP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2002739098

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)